GoldenGolden
Advanced Search
Clinithink

Clinithink

Clinithink a Natural Language Processing AI for structuring medical chart notations

All edits

Edits on 6 Aug, 2021
Golden AI"Inferring industry - ai.industry_clf.02"
Golden AI edited on 6 Aug, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Industry
Electronic health record
Edits on 14 May, 2021
Arjun Singh
Arjun Singh edited on 14 May, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 12 May, 2021
Golden AI"Funding autocalculation"
Golden AI edited on 12 May, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Latest funding type
Edits on 3 May, 2021
Bhupendra Solanki
Bhupendra Solanki edited on 3 May, 2021
Edits made to:
Infobox (+2 properties)
Infobox
Date incorporated
2009
Full address
555 NORTH POINT CENTER EAST, SUITE 400, ALPHARETTA, GA, 30022 United States
Edits on 9 Apr, 2021
Golden AI
Golden AI edited on 9 Apr, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 29 Mar, 2021
Golden AI"Found on funding round"
Golden AI edited on 29 Mar, 2021
Edits made to:
Infobox (+4 properties)
Infobox
Investors
Edits on 18 Feb, 2021
Henry Ogolla
Henry Ogolla approved a suggestion from Golden's AI on 18 Feb, 2021
Edits made to:
Article (+13/-13 characters)
Article

Clinithink currently holds an Early Stage Venture funding status. Their last funding roundfunding round was a Series B funding round that raised an unspecified amount of money in 2019. The previous funding rounds that were classified as Series A, took place in April & July of 2012. The lead investors in Clinithink are Merck and TT Capital Partners, however Vanguard Atlantic and Development Bank of Wales also made investments in the Series A - Clinithink Funding Round.

Edits on 17 Feb, 2021
Golden AI"prospector:155:86457"
Golden AI edited on 17 Feb, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Legal name
Clinithink Ltd
Edits on 6 Oct, 2020
Golden AI"Funding autocalculation"
Golden AI edited on 6 Oct, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Latest funding round date
March 3, 2019
Edits on 13 Aug, 2020
Edita Rexha"Approved suggestion #903047"
Edita Rexha edited on 13 Aug, 2020
Edits made to:
Infobox (+3 properties)
Article
Article

Infobox
Founded date
January 1, 2009
Edita Rexha"Approved suggestion #902072"
Edita Rexha edited on 13 Aug, 2020
Edits made to:
Article (+147 characters)
Article

Clinithink is a technology and services company focused on using Artificial Intelligence to deliver data insights for life science and healthcare.

Edits on 16 Jun, 2020
Erin Scherfner
Erin Scherfner edited on 16 Jun, 2020
Edits made to:
Timeline (+1 events) (+38 characters)
Timeline

2009

Clinithink founded by Chris Tackaberry
Erin Scherfner
Erin Scherfner approved a suggestion from Golden's AI on 16 Jun, 2020
Edits made to:
Article (+4/-4 characters)
Article

Clinithink is a technology and artificial intelligence services company, founded in 2009, with bases in the United States and in the United Kingdom. Clinithink patented an artificial intelligence program they developed called CLiXCLiX. CLiX is a language processing program that combs unstructured medical patient charts and returns the data to the system with structure.

Erin Scherfner
Erin Scherfner approved a suggestion from Golden's AI on 16 Jun, 2020
Edits made to:
Article (+13/-13 characters)
Article

Clinithink is a technology and artificial intelligence services company, founded in 2009, with bases in the United StatesUnited States and in the United Kingdom. Clinithink patented an artificial intelligence program they developed called CLiX. CLiX is a language processing program that combs unstructured medical patient charts and returns the data to the system with structure.

Erin Scherfner
Erin Scherfner approved a suggestion from Golden's AI on 16 Jun, 2020
Edits made to:
Article (+8/-8 characters)
Article

Clinithink currently holds an Early Stage Venture funding status. Their last funding round was a Series BSeries B funding round that raised an unspecified amount of money in 2019. The previous funding rounds that were classified as Series A, took place in April & July of 2012. The lead investors in Clinithink are Merck and TT Capital Partners, however Vanguard Atlantic and Development Bank of Wales also made investments in the Series A - Clinithink Funding Round.

Erin Scherfner
Erin Scherfner approved a suggestion from Golden's AI on 16 Jun, 2020
Edits made to:
Article (+19/-19 characters)
Article

Clinithink currently holds an Early Stage Venture funding status. Their last funding round was a Series B funding round that raised an unspecified amount of money in 2019. The previous funding rounds that were classified as Series A, took place in April & July of 2012. The lead investors in Clinithink are Merck and TT Capital PartnersTT Capital Partners, however Vanguard Atlantic and Development Bank of Wales also made investments in the Series A - Clinithink Funding Round.

Erin Scherfner
Erin Scherfner edited on 16 Jun, 2020
Edits made to:
Infobox (+1 properties)
Erin Scherfner
Erin Scherfner edited on 16 Jun, 2020
Edits made to:
Infobox (+1 properties)
Erin Scherfner
Erin Scherfner edited on 16 Jun, 2020
Edits made to:
Infobox (+4 properties)
Infobox
Industry
Erin Scherfner
Erin Scherfner edited on 16 Jun, 2020
Edits made to:
Article (+29/-124 characters)
Article

Clinithink is a technology and artificial intelligence services company, founded in 2009, with bases in the United States and in the United Kingdom. Clinithink patented aman artificial intelligence program they developed called CLiX. CLiX is a language processing program that combs unstructured medical patient charts and returns the data to the system with structure and purpose.

...

Clinithink felt that too much patient data and information was slipping through the cracks of disorganizeddeveloped chartingdue andto lack of conformity in medical charting practices.

...

Clinithink currently holds an Early Stage Venture funding status. Their last funding round was a Series B funding round that raised an unspecified amount of money in 2019. The previous funding rounds that were classified atas Series A, took place in April & July of 2012. The lead investors in Clinithink are Merck and TT Capital Partners, however Vanguard Atlantic and Development Bank of Wales have also made investments in the Series A - Clinithink Funding Round.

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.